A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

NCT06685757 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen